Maravai LifeSciences Holdings, Inc. MRVI Cygnus — G&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — g&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s cygnus — G&A?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — G&A of $1.37M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s cygnus — G&A changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s cygnus — G&A increased by 12.8% year-over-year, from $1.21M to $1.37M.
- What does cygnus — G&A mean?
- Covers the overhead costs required to support the Biologics Safety Testing segment, including management salaries, office expenses, and administrative support functions. This metric reflects the fixed cost base necessary to maintain business operations. Monitoring this helps evaluate the scalability of the segment's administrative infrastructure.